Date Title  
Jun 18, 2018
Summary ToggleSol-Gel Technologies Initiates Pivotal Phase III Clinical Program for Papulopustular Rosacea
 
May 29, 2018
Summary ToggleSol-Gel Technologies Announces Participation in Upcoming Investor Conferences
 
May 15, 2018
Summary ToggleSol-Gel Technologies Reports First Quarter 2018 Financial Results
 
Mar 26, 2018
Summary ToggleSol-Gel Technologies Ltd. Availability of Its Annual Report on Form 20-F Through Its Website
 
Mar 26, 2018
Summary ToggleSol-Gel Technologies Reports Fourth Quarter and Full Year 2017 Financial Results
 
Feb 15, 2018
Summary ToggleSol-Gel’s Phase 2 Data on TWIN and VERED to be Presented at the 2018 American Academy of Dermatology Annual Meeting
 
Feb 05, 2018
Summary ToggleSol-Gel Technologies Ltd. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
 
Jan 31, 2018
Summary ToggleSol-Gel Technologies Ltd. Announces Pricing of Initial Public Offering
 
Jul 20, 2017
Summary ToggleSol-Gel Announces Positive Phase 2 Clinical Trial Results for TWIN in Patients with Acne Vulgaris
 
Displaying 91 - 99 of 99 results